Background Fibrinolysis using streptokinase or tenecteplase remains the primary
reperfusion strategy for ST-elevation myocardial infarction (STEMI) in many Asian countries …

Myocardial infarction (MI) is a significant cause of morbidity and mortality in low-and middle-
income countries. Fibrinolytic agents and percutaneous coronary intervention (PCI) are the …

Once thrombi have formed as part of the pathology defining myocardial infarction, ischemic
stroke, peripheral arterial disease, deep venous thrombosis or other embolic disorders, the …

Fibrinolytic agents catalyze the conversion of the inactive proenzyme plasminogen into the
active protease plasmin, degrading fibrin within the thrombus and recanalizing occluded …

Objectives Spin is a reporting practice in which study results are misrepresented by
overestimating efficacy or underestimating harm. Prevalence of spin varies between clinical …

Streptokinase (SK) is an extracellular enzyme secreted by various strains of β-hemolytic
Streptococci. The main focus of the current study is to evaluate the in vitro thrombolytic …

Objective: Our primary objective was to compare the efficacy of streptokinase (SK),
tenecteplase, and reteplase by studying patients' electrocardiogram Electrocardiogram …

Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation
myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate …

Abstract Background Traditionally, the herb Byttneria pilosa Roxb. is used for bone fractures,
boils, scabies, rheumatalgia, snake bites, syphilis, elephantiasis, poisoning, and eye …

ABSTRACT BACKGROUND: Streptokinase is the most widely used thrombolytic agent and
can now be made using recombinant DNA technology. The present trial was initiated to …